ETHAN: A phase II study comparing different endocrine therapies for male breast cancer.

被引：0
|
作者：
Leone, Jose Pablo
Ruddy, Kathryn Jean
Rashid, Naim
Giordano, Sharon H.
Gupta, Gaorav P.
Hilsenbeck, Susan G.
Gucalp, Ayca
Walsh, Elaine M.
Sukumar, Jasmine S.
Makhlin, Igor
Ortiz-Perez, Tamara
Spanheimer, Philip Merle
Calhoun, Benjamin C.
Wolff, Antonio C.
Krop, Ian E.
Thompson, Alastair Mark
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[2] Mayo Clin, Rochester, MN USA
[3] Univ North Carolina Chapel Hill, Dept Biostat, Chapel Hill, NC USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[5] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[6] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX USA
[7] Mem Sloan Kettering Canc Ctr, New York, NY USA
[8] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[9] Univ Penn, Philadelphia, PA USA
[10] Baylor Coll Med, Houston, TX USA
[11] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[12] Yale Canc Ctr, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS632
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase II study of gastrimmune in advanced pancreatic cancer.
    Brett, BT
    Smith, SC
    Bouvier, CV
    Michaeli, D
    Hochhauser, D
    Davidson, BR
    Kurzawinski, TR
    Watkinson, T
    Van-Someren, N
    Pounder, RE
    Caplin, ME
    GASTROENTEROLOGY, 2000, 118 (04) : A642 - A642
  • [42] Neoadjuvant chemotherapy in the treatment of operable breast cancer. Preliminary results of a phase II pilot study
    Bellantone, R
    Lombardi, CP
    Cefaro, GA
    Rossi, S
    Nardone, L
    Minelli, S
    Raffaelli, M
    De Crea, C
    Crucitti, F
    10TH INTERNATIONAL CONGRESS ON SENOLOGY - BREAST DISEASES OF THE SENOLOGIC INTERNATIONAL SOCIETY, 1998, : 743 - 746
  • [43] A phase II study of capecitabine and weekly docetaxel combination chemotherapy in patients with metastatic breast cancer.
    Puglisi, F
    Scalone, S
    Minisini, AM
    Mansutti, M
    Crivellari, D
    Buonadonna, A
    Zanetti, M
    Ermacora, P
    Piga, A
    Veronesi, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 78S - 78S
  • [44] Phase II study of neo-adjuvant exemestane in postmenopausal patients with operable breast cancer.
    Tubiana-Hulin, M
    Spyratos, F
    Becette, V
    Mauriac, L
    Romieu, G
    Bibeau, F
    Bièche, I
    Bourgeois, H
    Chollet, P
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S106 - S106
  • [45] Phase II study of neoadjuvant therapy with epirubicin and docetaxel for women with locally advanced breast cancer.
    Holter, JL
    Tfayli, A
    Venkattapa, S
    Bova, A
    Howard, O
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 98S - 98S
  • [46] Vinorelbine and infusional 5-FU (VIF) - a phase II study in metastatic breast cancer.
    Stuart, N
    Bishop, J
    McIllmurray, M
    Price, C
    Johnston, SRD
    O'Reilly, S
    Joffe, J
    Neave, F
    Perren, T
    Crosby, T
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S91 - S91
  • [47] A phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer.
    Grecea, D
    Tanasescu, R
    Vasiliniuc, C
    Neamtiu, L
    Ghilezan, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 62S - 62S
  • [48] Late phase II study of S-1 in patients with taxane resistant breast cancer.
    Hino, M
    Saeki, T
    Sato, Y
    Sano, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 63S - 63S
  • [49] A phase II study of docetaxel and gemcitibine as neoadjuvant chemotherapy in stages IIIA & B breast cancer.
    Bitran, JD
    Kaiser, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 97S - 97S
  • [50] A Randomized Phase II Biomarker Study of Atorvastatin in Premenopausal Women at Increased Risk for Breast Cancer.
    Wood, M. E.
    Kingsley, F.
    Ellerton, J. A.
    Atkins, J. N.
    Grubs, S. S.
    Muss, H. B.
    Garber, J. E.
    CANCER RESEARCH, 2011, 71
12345